[HTML][HTML] Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
Oncotarget, 2017•ncbi.nlm.nih.gov
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of
granulocytic myeloid cells - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List Oncotarget v.8(34); 2017
Aug 22 PMC5593525 Other Formats PDF (9.5M) Actions Cite Collections Share Permalink
Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal …
granulocytic myeloid cells - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List Oncotarget v.8(34); 2017
Aug 22 PMC5593525 Other Formats PDF (9.5M) Actions Cite Collections Share Permalink
Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal …
Abstract
Purpose
Local immunosuppression remains a critical problem that limits clinically meaningful response to checkpoint inhibition in patients with head and neck cancer. Here, we assessed the impact of MDSC elimination on responses to CTLA-4 checkpoint inhibition.
ncbi.nlm.nih.gov